4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001209191-23-009711
Options or other derivatives
- Chief Financial Officer acquired 112,900 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
van Houte Hans · Chief Financial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-14 | Grant or award : show line 1 in the form Employee Stock Option (right to buy) | +88,900 | 88,900 | D |
| 2023-02-14 | Grant or award : show line 2 in the form Restricted Stock Units | +24,000 | 24,000 | D |
Loading xslF345X03/doc4.xml…